Clinical Trials
70 trialsIscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma
Hackensack Meridian Health
SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma
M.D. Anderson Cancer Center
Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma
Sun Yat-sen University
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
National Institutes of Health Clinical Center (CC)
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
Memorial Sloan Kettering Cancer Center
panSOHO
Bayer
ALBATROSS
Yonsei University
Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
Memorial Sloan Kettering Cancer Center
Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma
M.D. Anderson Cancer Center
ANTARES
Instituto do Cancer do Estado de São Paulo
5-Day Preoperative Radiation for Soft Tissue Sarcoma
Stanford University
Efficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard Treatment
Second Affiliated Hospital, School of Medicine, Zhejiang University
Propranolol for the Treatment of Kaposi Sarcoma in Adults
Washington University School of Medicine
CIRTUSARC
Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas
Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma
Medical University of South Carolina
neoSFRT-SARC
Second Affiliated Hospital, School of Medicine, Zhejiang University
ISG-ARTICLE
Italian Sarcoma Group
IVIM & OLINK in Sarcoma
University Health Network, Toronto
A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
QBiotics Group Limited
Phase II Trial of Lung Chemoemobolization
City of Hope Medical Center
Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Wake Forest University Health Sciences
BAL Fluid Biomarkers in Sarcoma
University Health Network, Toronto
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
University of California, Irvine
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
M.D. Anderson Cancer Center
ICGTM
University of Pittsburgh
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
University of Colorado, Denver
Hypofractionated vs Conventional Fractionated RT in Soft Tissue Sarcomas
University of Wisconsin, Madison
PROSARC-1
Oslo University Hospital
PROSARC-2
Oslo University Hospital
MAGNATE-S
Shanghai 6th People's Hospital
TAIS
Fudan University
TNT-HYPE
Swiss Cancer Institute
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
Sarcoma Alliance for Research through Collaboration
AcSé HER2
UNICANCER
SPARE-01
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Pan-MSI-ACSE
UNICANCER
PEMBROCABOSARC
Institut Bergonié
Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
Ohio State University Comprehensive Cancer Center
CAPTIV-8
British Columbia Cancer Agency
EPOP-SARCOMA
Institut Claudius Regaud
A Trial of ABSK043, an Oral PD-L1 Inhibitor, in Patients With Angiogenic Sarcomas
University Health Network, Toronto
Ivonescimab in the Treatment of Multiple Advanced Tumors
Fudan University
Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma
Oslo University Hospital
TRUST
Institut Bergonié
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Nationwide Children's Hospital
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
HRYZ Biotech Co.
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Medical College of Wisconsin
Pazopanib With or Without Pembrolizumab for Metastatic Soft Tissue Sarcoma
Yonsei University
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
University of Pittsburgh